|Description||Biology Decision Support Software|
|Angel, 1/11 ||$1.6M|
|Series A, 1/13 |
The Social+Capital Partnership
Syapse is disrupting healthcare by bringing -omics into routine medical use. Built on a powerful cloud-based semantic data platform, Syapse applications enable the generation and use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. Led by an experienced, multidisciplinary team of entrepreneurs, software developers, and scientists, Syapse was founded at Stanford University and is backed by The Social+Capital Partnership.